Rym BENKHALIFA

Dr. Rym BENKHALIFA

Laboratory of Venom and Therapeutical Molecules Institut Pasteur Tunis
+1
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2018 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
HJHager Jaouadi
Hager Jaouadi
LKLilia Kraoua
Lilia Kraoua
LCLilia Chaker
Lilia Chaker
AAAlexandre Atkinson
Alexandre Atkinson
VDValérie Delague
Valérie Delague
Stéphane ZaffranStéphane Zaffran
Stéphane Zaffran

7 July 2025 in Molecules
Verified
Journal Article
Open access
PDF file
Fatiha BrahmiFatiha Brahmi
Fatiha Brahmi
John MackrillJohn Mackrill
John Mackrill
IGImen GHZAIEL
Imen GHZAIEL
LRLeila Rezig
Leila Rezig
RBRym BENKHALIFA
Rym BENKHALIFA
Gérard Hubert LizardGérard Hubert Lizard
Gérard Hubert Lizard
Oxysterols can be derived from the diet, physiologically produced via specific enzymes, or are generated by autoxidation. These molecules have physiological properties and can also adversely affect vital organs. Indeed, some of them have pro-oxidant and pro-inflammatory activities and can lead to major pathologies. The present review focuses on oxysterols (7-ketocholesterol, 7β-hydroxycholesterol, 25-hydroxycholesterol, 27-hydroxycholesterol, 5,6α-epoxycholesterol, 5,6β-epoxycholesterol, and cholestane-3β, 5α, 6β-triol) involved either in cholesterol metabolism, age-related diseases (such as cardiovascular, neurodegenerative, and eye diseases, e.g., sarcopenia), and inflammatory diseases (especially Behcet’s disease and bowel and lung diseases (e.g., sarcoidosis, COVID-19)). Metabolic pathways associated with oxysterol-induced inflammation are discussed considering the cytokinic TLR4 pathway, non-cytokinic pathways, and the contribution of Ca2+ and K+ channels. Therapeutic approaches targeting oxysterol-induced inflammation either by natural or synthetic molecules are also presented.

29 May 2018 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
HJHager Jaouadi
Hager Jaouadi
AZAnissa Zaouak
Anissa Zaouak
KSKhadija Sellami
Khadija Sellami
OMOlfa Messaoud
Olfa Messaoud
MCMariem Chargui
Mariem Chargui
SASonia Abdelhak
Sonia Abdelhak

Verified
Journal Article
Open access
PDF file
THTABKA Hager
TABKA Hager
ACAmani Cheikh
Amani Cheikh
SMSonia Maatoug
Sonia Maatoug
MAMohamed El Ayeb
Mohamed El Ayeb
SBSaïd Bendahhou
Saïd Bendahhou
RBRym BENKHALIFA
Rym BENKHALIFA
Kv3.1 channel is abundantly expressed in neurons and its dysfunction causes sleep loss, neurodegenerative diseases and depression. Fluoxetine, a serotonin selective reuptake inhibitor commonly used to treat depression, acts also on Kv3.1. To define the relationship between Kv3.1 and serotonin receptors (SR) pharmacological modulation, we showed that 1C11, a serotonergic cell line, expresses different voltage gated potassium (VGK) channels subtypes in the presence (differentiated cells (1C11D)) or absence (not differentiated cells (1C11ND)) of induction. Only Kv1.2 and Kv3.1 transcripts increase even if the level of Kv3.1b transcripts is highest in 1C11D and, after fluoxetine, in 1C11ND but decreases in 1C11D. The Kv3.1 channel protein is expressed in 1C11ND and 1C11D but is enhanced by fluoxetine only in 1C11D. Whole cell measurements confirm that 1C11 cells express (VGK) currents, increasing sequentially as a function of cell development. Moreover, SR 5HT1b is highly expressed in 1C11D but fluoxetine increases the level of transcript in 1C11ND and significantly decreases it in 1C11D. Serotonin dosage shows that fluoxetine at 10 nM blocks serotonin reuptake in 1C11ND but slows down its release when cells are differentiated through a decrease of 5HT1b receptors density. We provide the first experimental evidence that 1C11 expresses Kv3.1b, which confirms its major role during differentiation. Cells respond to the fluoxetine effect by upregulating Kv3.1b expression. On the other hand, the possible relationship between the fluoxetine effect on the kinetics of 5HT1b differentiation and Kv3.1bexpression, would suggest the Kv3.1b channel as a target of an antidepressant drug as well as it was suggested for 5HT1b.

14 September 2024 in Toxins
Verified
Journal Article
Open access
PDF file
HMHiba Mejri
Hiba Mejri
RMRym MOKRANI
Rym MOKRANI
AKAyoub Ksouri
Ayoub Ksouri
MSMabrouk Seddik
Mabrouk Seddik
NANour Awad
Nour Awad
BBBalkiss Bouhaouala-Zahar
Balkiss Bouhaouala-Zahar
Snakebite envenoming (SBE) remains a severely neglected public health issue, particularly affecting tropical and subtropical regions, with Africa experiencing an estimated 435,000 to 580,000 snakebites annually, leading to high morbidity and mortality rates, especially across Africa and Asia. Recognized as a Neglected Tropical Disease, SBE management is further complicated by the inadequate efficacy of current antivenom treatments. Of particular concern are cobras (Naja sp.), whose neurotoxins can induce rapid fatal respiratory paralysis. In this study, we investigate the potential of nanobodies as a promising next-generation of immunotherapeutics against cobra venoms. Through a dual strategy of the characterization of venom toxic fractions from cobras captured for the first time in Algeria and Tunisia biotopes, coupled with in vitro assays to evaluate their interactions with acetylcholine receptors, and subsequent immunization of dromedaries to produce specific nanobodies, we identified two lethal fractions, F5 and F6, from each venom, and selected five nanobodies with significant binding and neutralizing of 3DL50 (0.74 mg/kg). The combination of these nanobodies demonstrated a synergistic effect, reaching 100% neutralizing efficacy of 2DL50 lethal venom fraction (0.88 mg/kg) doses in mice. Additionally, our findings highlighted the complex mechanism of cobra venom action through the lethal synergism among its major toxins.

31 January 2007 in Toxicon
Verified
Journal Article
Closed access
ACAmani Cheikh
Amani Cheikh
RBRym BENKHALIFA
Rym BENKHALIFA
DPDaniel Potreau
Daniel Potreau
GRGuy Raymond
Guy Raymond
MAMohamed El Ayeb
Mohamed El Ayeb
CCChristian Cognard
Christian Cognard